Pharmacological modulation of cell adhesion molecules

European Journal of Pharmacology

Volumn 344, Issue 1, 1998, Pages 1-13

  Henricks, Paul A J ^a   Nijkamp, Frans P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adhesion; Anti adhesion therapy; Inflammation; Leukocyte

Indexed keywords

ACETYLSALICYLIC ACID; ANTISENSE OLIGONUCLEOTIDE; CADHERIN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID; ICOSANOID; IMMUNOGLOBULIN; INDOMETACIN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; LEUMIDIN; METHYLPREDNISOLONE; N (2,7 DIMETHYL 9 FLUORENYLMETHOXYCARBONYL)LEUCINE; NONSTEROID ANTIINFLAMMATORY AGENT; NPC 15199; PADGEM PROTEIN; PIROXICAM; SCLEROPROTEIN; SELECTIN; TENIDAP; TEPOXALIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CELL ADHESION; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MODULATION; MORPHOGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE INJURY;

ANIMALS; CELL ADHESION MOLECULES; HUMANS;

EID: 0032567902     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00036-3     Document Type: Review

References (181)

1. 4-Integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J. Clin. Invest. 93:1994;776-787.
2. 2. Eur. J. Pharmacol. 326:1997;237-250.
3. Anderson D.C., Springer T.A. Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1 and p150,95 glycoproteins. Annu. Rev. Med. 38:1987;175-194.
4. Andrews F.J., Malcontenti-Wilson C., O'Brien P.E. Effect of nonsteroidal anti-inflammatory drugs on LFA-1 and ICAM-1 expression in gastric mucosa. Am. J. Physiol. 266:1994;G657-G664.
5. Asako H., Kubes P., Wallace J., Wolf R.E., Granger D.N. Modulation of leukocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology. 103:1992;146-152.
6. Asako H., Kubes P., Wallance J., Gaginella T., Wolf R.E., Granger D.N. Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am. J. Physiol. 262:1992;G903-G908.
7. Austrup F., Vestweber D., Borges E., Löhning M., Bräuer R., Herz U., Renz H., Hallmann R., Scheffold A., Radbruch A., Hamann A. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature. 385:1997;81-83.
8. Baker B.F., Lot S.S., Condon T.P., Cheng-Flournoy S., Lesnik E.A., Sasmor H.M., Bennett C.F. 2′-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells. J. Biol. Chem. 272:1997;11994-12000.
9. Bator J.M., Weitzberg M., Burch R.M. N-[9H-(2,7-dimethylfluorenyl-9-methoxy)carbonyl]-L-leucine, NPC 15669, prevents neutrophil adherence to endothelium and inhibits CD11b/CD18 upregulation. Immunopharmacology. 23:1992;139-149.
10. Bator J.M., Gillinov A.M., Zehr K.J., Redmond J.M., Wilson I.C., Herskowitz A., Conner J.R., Burch R.M., Cameron D.E. NPC 15669 blocks neutrophil CD18 increase and lung injury during cardiopulmonary bypass in pigs. Med. Inflammation. 2:1993;135-141.
11. Baumhueter S., Singer M.S., Henzel W., Hemmerich S., Renz M., Rosen S.D., Lasky L.A. Binding of L-selectin to the vascular sialomucin CD34. Science. 262:1993;436-438.
12. Bennett C.F., Condon T.P., Grimm S., Chan H., Chiang M.-Y. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152:1994;3530-3540.
13. Bennett C.F., Kornbrust D., Henry S., Stecker K., Howard R., Cooper S., Dutson S., Hall W., Jacoby H.I. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis. J. Pharmacol. Exp. Ther. 280:1997;988-1000.
14. Bentley A.M., Durham S.R., Robinson D.S., Menz G., Storz C., Cromwell O., Kay A.B., Wardlaw A.J. Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J. Allergy Clin. Immunol. 92:1993;857-868.
15. Berger M., Birx D.L., Wetzler E.M., O'Shea J.J., Brown E.J., Cross A.S. Calcium requirements for increased complement receptor expression during neutrophil activation. J. Immunol. 135:1985;1342-1348.
16. Bevilacqua M.P., Nelson R.M. Selectins. J. Clin. Invest. 91:1993;379-387.
17. Bevilacqua M.P., Stengelin S., Gimbrone M.A. Jr., Seed B. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 243:1989;1160-1165.
18. Bevilacqua M.P., Nelson R.M., Mannori G., Cecconi O. Endothelial-leukocyte adhesion molecules in human disease. Annu. Rev. Med. 45:1994;361-378.
19. Bloemen P.G.M., Van den Tweel M.C., Henricks P.A.J., Engels F., Wagenaar S.S., Rutten A.A.J.J.L., Nijkamp F.P. Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 9:1993;586-593.
20. Bloemen P.G.M., Henricks P.A.J., Van Bloois L., Van den Tweel M.C., Bloem A.C., Nijkamp F.P., Crommelin D.J.A., Storm G. Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett. 357:1995;140-144.
21. Bloemen P.G.M., Buckley T.L., Van den Tweel M.C., Henricks P.A.J., Redegeld F.A.M., Koster A.S., Nijkamp F.P. LFA-1, and not Mac-1, is crucial for the development of hyperreactivity in a murine model of nonallergic asthma. Am. J. Respir. Crit. Care Med. 153:1996;521-529.
22. Bloemen P.G.M., Van den Tweel M.C., Henricks P.A.J., Engels F., Kester M.H.A., Van de Loo P.G.F., Blomjous F.J., Nijkamp F.P. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am. J. Physiol. 272:1997;L580-L587.
23. Bochner B.S., Klunk D.A., Sterbinsky S.A., Coffman R.L., Schleimer R.P. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154:1995;799-803.
24. Bondeson J. Effects of tenidap on intracellular signal transduction and the induction of proinflammatory cytokines: a review. Gen. Pharmacol. 27:1996;943-956.
25. Briggs J.B., Oda Y., Gilbert J.H., Schaefer M.E., Macher B.A. Peptides inhibit selectin-mediated cell adhesion in vitro, and neutrophil influx into inflammatory sites in vivo. Glycobiology. 5:1995;583-588.
26. Brostjan C., Anrather J., Csizmadia V., Natarajan G., Winkler H. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-jun. J. Immunol. 158:1997;3836-3844.
27. Buckley T.L., Bloemen P.G.M., Henricks P.A.J., Van den Tweel M.C., Redegeld F.A.M., Koster A.S., Nijkamp F.P. LFA-1 and ICAM-1 are crucial for the induction of hyperreactivity in the mouse airways. Ann. N.Y. Acad. Sci. 796:1996;149-161.
28. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 93:1994;1140-1148.
29. Burch R.M., Weitzberg M., Blok N., Muhlhauser R., Martin D., Farmer S.G., Bator J.M., Conner J.R., Ko C., Kuhn W., McMillan B.A., Raynor M., Shearer B.G., Tiffany C., Wilkins D.E. N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action. Proc. Natl. Acad. Sci. USA. 88:1991;355-359.
30. Burch R.M., Connor J.R., Bator J.M., Weitzberg M., Laemont K., Noronha-Blob L., Sullivan J.P., Steranka L.R. NPC 15669 inhibits the reversed passive arthus reaction in rats by blocking neutrophil recruitment. J. Pharmacol. Exp. Ther. 263:1992;933-937.
31. Burch R.M., Weitzberg M., Noronha-Blob L., Lowe V.C., Bator J.M., Perumattam J., Sullivan J.P. Leumidines. Drugs News Perspectives. 5:1992;331-337.
32. Burch R.M., Noronha-Blob L., Bator J.M., Lowe V.C., Sullivan J.P. Mice treated with a leumidin or antibody to Mac-1 to inhibit leukocyte sequestration survive endotoxin challenge. J. Immunol. 150:1993;3397-3403.
33. Burke-Gaffney A., Hellewell P.G. Regulation of ICAM-1 by dexamethasone in a human vascular endothelial cell line EAhy926. Am. J. Physiol. 270:1996;C552-C561.
34. Burton J.L., Kehrli M.E. Jr., Kapil S., Horst R.L. Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone. J. Leukocyte Biol. 57:1995;317-325.
35. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1991;1033-1036.
36. 1 interaction with connecting segment 1 and vascular cell adhesion molecule. J. Biol. Chem. 269:1994;18668-18673.
37. Carlos T.M., Harlan J.M. Leukocyte-endothelial adhesion molecules. Blood. 84:1994;2068-2101.
38. 7 integrin. Nature. 372:1994;190-193.
39. 1 inhibits neutrophil adherence and neutrophil-mediated injury to cultured endothelial cells. Am. Rev. Respir. Dis. 138:1988;915-920.
40. Clària J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. USA. 92:1995;9475-9479.
41. Clark E.A., Brugge J.S. Integrins and signal transduction pathways: the road taken. Science. 268:1995;233-239.
42. Coller B.S. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy. Circulation. 92:1995;2373-2380.
43. Coller B.S. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J. Clin. Invest. 99:1997;1467-1471.
44. Condon T.P., Bennett C.F. Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells. J. Biol. Chem. 271:1996;30398-30403.
45. Crockett-Torabi E., Fantone J.C. The selectins: insight into selectin-induced intracellular signaling in leukocytes. Immunol. Res. 14:1995;237-251.
46. Cronstein B.N., Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum. 36:1993;147-157.
47. Cronstein B.N., Kimmel S.C., Levin R.I., Martiniuk F., Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 89:1992;9991-9995.
48. Crooke S.T., Bennett C.F. Progress in antisense oligonucleotide therapeutics. Annu. Rev. Pharmacol. Toxicol. 36:1996;107-129.
49. 2 integrin CD11b/CD18. Proc. Natl. Acad. Sci. USA. 88:1991;3106-3110.
50. Davis L.S., Kavanaugh A.F., Nichols L.A., Lipsky P.E. Induction of persistent T cell hyporesponsiveness in vivo by monoclonal antibody to ICAM-1 in patients with rheumatoid arthritis. J. Immunol. 154:1995;3525-3537.
51. Dean N.M., McKay R., Miraglia L., Geiger T., Müller M., Fabbro D., Bennett C.F. Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents. Biochem. Soc. Trans. 24:1996;623-629.
52. De Fougerolles A.R., Stacker S.A., Schwarting R., Springer T.A. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174:1991;253-267.
53. Diaz-González F., González-Alvaro I., Campanero M.R., Mollinedo F., del Pozo M.A., Muñoz C., Pivel J.P., Sánchez-Madrid F. Prevention of in vitro neutrophil-endothelial attachment through shedding of L-selectin by nonsteroidal antiinflammatory drugs. J. Clin. Invest. 95:1995;1756-1765.
54. Díaz-González F., Forsyth J., Steiner B., Ginsberg M.H. Trans-dominant inhibition of integrin function. Mol. Biol. Cell. 7:1996;1939-1951.
55. 1 inhibited PMN attachment to air emboli in vivo during infusion of ZAP without preventing lung injury. J. Appl. Physiol. 72:1992;340-351.
56. Elices M.J., Tsai V., Strahl D., Goel A.S., Tollefson V., Arrhenius T., Wayner E.A., Gaeta F.C.A., Fikes J.D., Firestein G.S. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J. Clin. Invest. 93:1994;405-416.
57. 2(Mac-1)-dependent neutrophil adhesion without blocking activation-induced changes in Mac-1. J. Pharmacol. Exp. Ther. 276:1996;5-12.
58. Endemann G., Abe Y., Bryant C.M., Feng Y., Smith C.W., Liu D.Y. Novel anti-inflammatory compounds induce shedding of L-selectin and block primary capture of neutrophils under flow conditions. J. Immunol. 158:1997;4879-4885.
59. Etzioni A., Frydman M., Pollack S., Avidor I., Phillips M.L., Paulson J.C., Gershoni-Baruch R. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. New Engl. J. Med. 327:1992;1789-1792.
60. Farsky S.P., Sannomiya P., Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study. J. Leukocyte Biol. 57:1995;379-386.
61. Fecondo J.V., Kent S.B.H., Boyd A.W. Inhibition of intercellular adhesion molecule 1-dependent biological activities by a synthetic peptide analog. Proc. Natl. Acad. Sci. USA. 88:1991;2879-2882.
62. Forsyth K.D., Talbot V. Role of glucocorticoids in neutrophil and endothelial adhesion molecule expression and function. Mediators Inflamm. 1:1992;101-106.
63. Friedman M., Wang S.Y., Sellke F.W., Cohn W.E., Weintraub R.M., Johnson R.G. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 111:1995;460-468.
64. Garciá-Vicuña R., Díaz-González F., del Pozo M.A., Mollinedo F., Cabañas C., González-Amaro R., Sánchez-Madrid F. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. Arthritis Rheum. 40:1997;143-153.
65. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today. 14:1993;506-512.
66. Georas S.N., Liu M.C., Newman W., Beall L.D., Stealey B.A., Bochner B.S. Altered adhesion molecule expression and endothelial activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. Am. J. Respir. Cell Mol. Biol. 7:1992;261-269.
67. Giancotti F.G. Integrin signaling: specificity and control of cell survival and cell cycle progression. Curr. Opin. Cell Biol. 9:1997;691-700.
68. 4 stimulates polymorphonuclear leukocyte adhesion to cultured vascular endothelial cells. J. Clin. Invest. 74:1984;1552-1555.
69. González-Alvaro I., Carmona L., Díaz-González F., González-Amaro R., Mollinedo F., Sánchez-Madrid F., Laffón A., García-Vicuña R. Aceclofenac, a new nonsteroidal antiinflammatory drug, decrease the expression and function of some adhesion molecules in human neutrophils. J. Rheumatol. 23:1996;723-729.
70. Gonzalo J.-A., Lloyd C.M., Kremer L., Finger E., Martinez-A C., Siegelman M.H., Cybulsky M., Gutierrez-Ramos J.-C. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines and adhesion receptors. J. Clin. Invest. 98:1996;2332-2345.
71. Gosset P., Tillie-Leblond I., Janin A., Marquette C.-H., Copin M.-C., Wallaert B., Tonnel A.-B. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int. Arch. Allergy Immunol. 106:1995;69-77.
72. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 84:1996;345-357.
73. Haller H., Dragun D., Miethke A., Park J.K., Weis A., Lippoldt A., Groß V., Luft F.C. Kidney Int. 50:1996;473-480.
74. Hamilton G.S., Mewshaw R.E., Bryant C.M., Feng Y., Endemann G., Madden K.S., Janczak J.E., Perumattam J., Stanton L.W., Yang X., Yin Z. Fluorenylalkanoic and benzoic acids as novel inhibitors of cell adhesion processes in leukocytes. J. Med. Chem. 38:1995;1650-1656.
75. Haynes B.F., Telen M.J., Hale L.P., Denning S.M. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today. 10:1989;423-428.
76. Horie S., Kita H. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J. Immunol. 152:1994;5457-5467.
77. Huang Y.-W., Baluna R., Visetta E.S. Adhesion molecules as targets for cancer therapy. Histol. Histopathol. 12:1997;467-477.
78. Hunt III, S.W., Kellermann, S.-A., Shimizu, Y., 1997. Integrins, integrin regulators, and the extracellular matrix. The role of signal transduction and leukocyte migration. In: Bochner, B.S. (Ed.), Adhesion Molecules in Allergic Disease. Marcel Dekker, New York, pp. 73-103.
79. Iademarco M.F., Barks J.L., Dean D.C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J. Clin. Invest. 95:1995;264-271.
80. Imai Y., Lasky L.A., Rosen S.D. Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature. 361:1993;555-557.
81. 2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells. Eur. J. Pharmacol. 262:1994;113-123.
82. 2. J. Immunol. 151:1993;5639-5652.
83. 2 synthase inhibitor, DP-1904, decreases TNFα secretion from monocytes and inhibits E-selectin and ICAM-1 expression on the endothelial surfaces. Adv. Prostaglandin Thromboxane Leukotriene Res. 23:1995;423-425.
84. Katz S.M., Tian L., Stepkowski S.M., Phan T., Bennett C.F., Kahan B.D. Effect of ICAM-1/LFA-1 blockade on pancreatic islet allograft survival, function, and early cytokine production. Transplant. Proc. 29:1997;748-749.
85. Kavanaugh, A., 1997. Overview of cell adhesion molecules and their antagonism. In: Bochner, B.S. (Ed.), Adhesion Molecules in Allergic Disease. Marcel Dekker, New York, pp. 1-24.
86. Kavanaugh A., Nichols L., Davis L., Rothlein R., Lipsky P. Anti-CD54 (intercellular adhesion molecule-1; ICAM-1) monoclonal antibody therapy in refractory rheumatoid arthritis. Arthritis Rheum. 36:1993;S40.
87. Kavanaugh A.F., Davis L.S., Nichols L.A., Norris S.H., Rothlein R., Scharschmidt L.A., Lipsky P.E. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37:1994;992.
88. Kazmi S.M.I., Plante R.K., Visconti V., Taylor G.R., Zhou L., Lau C.Y. Suppression of NFkB activation and NFkB-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. J. Cell. Biochem. 57:1995;299-310.
89. Kincade P.W., Zheng Z., Katoh S., Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9:1997;635-642.
90. Kirchner T., Aparicio B., Argentieri D.C., Lau C.Y., Ritchie D.M. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation. Prostaglandins Leukotrienes Essent. Fatty Acids. 56:1997;417-423.
91. Kogan T.P., Dupré B., Keller K.M., Scott I.L., Bui H., Market R.V., Beck P.J., Voytus J.A., Revelle B.M., Scott D. Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: (α-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids. J. Med. Chem. 38:1995;4976-4984.
92. Konstantopoulos K., McIntire L.V. Effects of fluid dynamic forces on vascular cell adhesion. J. Clin. Invest. 98:1996;2661-2665.
93. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-959.
94. Kruszynski M., Nakada M.T., Tam S.H., Taylor A.H., Fieles W.E., Heavner G.A. Determination of the core sequence of an antagonist of selectin-dependent leukocyte adhesion and correlation of its structure with molecular modeling studies. Arch. Biochem. Biophys. 331:1996;23-30.
95. Kumasaka T., Quinlan W.M., Doyle N.A., Condon T.P., Sligh J., Takei F., Beaudet A.L., Bennett C.F., Doerschuk C.M. Role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J. Clin. Invest. 97:1996;2362-2369.
96. Kurose I., Wolf R., Miyasaka M., Anderson D.C., Granger D.N. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. Am. J. Physiol. 270:1996;G363-G369.
97. Kyan-Aung U., Lee T.H., Haskard D.O. The inhibitory effect of tenidap on leukocyte-endothelial cell adhesion. J. Rheumatol. 20:1993;1014-1019.
98. Laberge S., Rabb H., Issekutz T.B., Martin J.G. Role of VLA-4 and LFA-1 in allergen-induced airway hyperresponsiveness and lung inflammation in the rat. Am. J. Respir. Crit. Care Med. 151:1995;822-829.
99. Lee D.H.S., Tam S.S.C., Wang E., Taylor G.R., Plante R.K., Lau C.Y. The NF-κB inhibitor, tepoxalin, suppresses surface expression of the cell adhesion molecules CD62E, CD11b/CD18 and CD106. Immunol. Lett. 53:1996;109-113.
100. x analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion. Circulation. 90:1994;2390-2401.
101. Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New Engl. J. Med. 332:1995;1553-1559.
102. 4 induces hyperadhesiveness in human endothelial cells for neutrophils. Blood. 82:1993;948-953.
103. Lobb, R.R., 1997. Adhesion molecule antagonists in animal models of asthma. In: Bochner, B.S. (Ed.), Adhesion Molecules in Allergic Asthma. Marcel Dekker, New York, pp. 393-405.
104. Loftus J.C., Liddington R.C. New insights into integrin-ligand interaction. J. Clin. Invest. 99:1997;2302-2306.
105. Look D.C., Rapp S.R., Keller B.T., Holtzman M.J. Selective induction of intercellular adhesion molecule-1 by interferon-γ in human airway epithelial cells. Am. J. Physiol. 263:1992;L79-L87.
106. Lowe J.B., Ward P.A. Therapeutic inhibition of carbohydrate-protein interactions in vivo. J. Clin. Invest. 99:1997;822-826.
107. Luscinskas, F.W., 1997. The endothelium in leukocyte recruitment. In: Bochner, B.S. (Ed.), Adhesion Molecules in Allergic Disease. Marcel Dekker, New York, pp. 25-41.
108. Malik A.B., Lo S.K. Vascular endothelial adhesion molecules and tissue inflammation. Pharmacol. Rev. 48:1996;213-229.
109. McCafferty D.-M., Kubes P., Wallace J.L. Inhibition of platelet-activating factor-induced leukocyte adhesion in vivo by a leumidin. Eur. J. Pharmacol. 232:1993;169-172.
110. McEver R.P., Cummings R.D. Role of PSGL-1 binding to selectins in leukocyte recruitment. J. Clin. Invest. 100:1997;485-492.
111. McEver R.P., Beckstead J.H., Moore K.L., Marshall-Carlson L., Bainton D.F. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is located in Weibel-Palade bodies. J. Clin. Invest. 84:1989;92-99.
112. Menger M.D., Vollmar B. Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br. J. Surg. 83:1996;588-601.
113. Milne A.A.Y., Piper P.J. The effects of two anti-CD18 antibodies on antigen-induced airway hyperresponsiveness and leukocyte accumulation in the guinea pig. Am. J. Respir. Cell Mol. Biol. 11:1994;337-343.
114. Milne A.A.Y., Piper P.J. Role of VLA-4 integrin in leucocyte recruitment and bronchial hyperresponsiveness in the guinea-pig. Eur. J. Pharmacol. 282:1995;243-249.
115. Molossi S., Elices M., Arrhenius T., Diaz R., Coulber C., Rabinovitch M. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J. Clin. Invest. 95:1995;2601-2610.
116. Montefort S., Gratziou C., Goulding D., Polosa R., Haskard D.O., Howarth P.H., Holgate S.T., Carroll M.P. Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J. Clin. Invest. 93:1994;1411-1421.
117. Montefort S., Lai C.K.W., Kapahi P., Leung J., Lai K.N., Chan H.S., Haskard D.O., Howarth P.H., Holgate S.T. Circulating adhesion molecules in asthma. Am. J. Respir. Crit. Care Med. 149:1994;1149-1152.
118. Morland C.M., Wilson S.J., Holgate S.T., Roche W.R. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. Am. J. Respir. Cell Mol. Biol. 6:1992;557-566.
119. Moser R., Fehr J., Bruijnzeel P.L.B. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J. Immunol. 149:1992;1432-1438.
120. Mulligan M.S., Lowe J.B., Larsen R.D., Paulson J., Zheng Z., DeFrees S., Maemura K., Fukuda M., Ward P.A. Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J. Exp. Med. 178:1993;623-631.
121. Mulligan M.S., Paulson J.C., De Frees S., Zheng Z.-L., Lowe J.B., Ward P.A. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature. 364:1993;149-151.
122. Nagase T., Fukuchi Y., Matsuse T., Sudo E., Matsui H., Orimo H. Antagonism of ICAM-1 attenuates airway and tissue responses to antigen in sensitized rats. Am. J. Respir. Crit. Care Med. 151:1995;1244-1249.
123. Nagata M., Sedgwick J.B., Bates M.E., Kita H., Busse W.W. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J. Immunol. 155:1995;2194-2202.
124. Nakajima H., Sano H., Nishimura T., Yoshida S., Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J. Exp. Med. 179:1994;1145-1154.
125. Neeley S.P., Hammann K.J., White S.R., Baranowski S.L., Burch R.A., Leff A.R. Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin, and VLA-4 on human eosinophils and neutrophils. Am. J. Respir. Cell Mol. Biol. 8:1993;633-639.
126. Nelson R.M., Dolich S., Aruffo A., Ceconi O., Bevilacqua M.P. Higher-affinity oligosaccharide ligands for E-selectin. J. Clin. Invest. 91:1993;1157-1166.
127. Noronha-Blob L., Lowe V.C., Weitzberg M., Burch R.M. NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice. Eur. J. Pharmacol. 199:1991;387-388.
128. Noronha-Blob L., Lowe V.C., Muhlhauser R.O., Burch R.M. NPC 15669, an inhibitor of neutrophil recruitment, is efficious in acetic acid-induced colitis in rats. Gastroenterology. 104:1993;1021-1029.
129. Noronha-Blob L., Lowe V.C., Otterbein L., Steranka L., Burch R.M. NPC 15669 reduces mortality associated with sepsis in rats. J. Pharmacol. Exp. Ther. 267:1993;664-669.
130. Ohkawara Y., Yamauchi K., Maruyama N., Hoshi H., Ohno I., Honma M., Tanno Y., Tamura G., Shirato K., Ohtani H. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 12:1995;4-12.
131. O'Leary E.C., Marder P., Zuckerman S.H. Glucocorticoid effects in an endotoxin-induced rat pulmonary inflammation model: differential effects on neutrophil influx, integrin expression, and inflammatory mediators. Am. J. Respir. Cell Mol. Biol. 15:1996;97-106.
132. Paleolog E.M., Hunt M., Elliott M.J., Feldmann M., Maini R.N., Woody J.N. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor α antibody in rheumatoid arthritis. Arthritis Rheum. 39:1996;1082-1091.
133. Palmblad J.E.W., Lerner R. Leukotriene B4-induced hyperadhesiveness of endothelial cells for neutrophils: relation to CD54. Clin. Exp. Immunol. 90:1992;300-304.
134. 4 induced hyperadhesiveness of endothelial cell for neutrophils. J. Immunol. 152:1994;262-269.
135. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156:1996;2264-2272.
136. Perretti M., Wheller S.K., Harris J.G., Flower R.J. Modulation of ICAM-1 levels on U-937 cells and mouse macrophages by interleukin-1β and dexamethasone. Biochem. Biophys. Res. Commun. 223:1996;112-117.
137. Pitzalis C., Sharrack B., Gray I.A., Lee A., Hughes R.A.C. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis. J. Neuroimmunol. 74:1997;62-68.
138. Pober J.S., Gimbrone M.A. Jr., Lapierre L.A., Mendrick D.L., Fiers W., Rothlein R., Springer T.A. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J. Immunol. 137:1986;1893-1896.
139. 1/VCAM-1 adhesion pathway in physiology and disease. Res. Immunol. 145:1994;723-735.
140. Pretolani M., Ruffié C., Lapa e Silva J.-R., Joseph D., Lobb R.R., Vargaftig B.B. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J. Exp. Med. 180:1994;795-805.
141. Rao B.N.N., Anderson M.B., Musser J.H., Gilbert J.H., Schaeffer M.E., Foxall C., Brandley B.K. Sialyl Lewis X mimics derived from a pharmacophore search are selectin inhibitors with anti-inflammatory activity. J. Biol. Chem. 269:1994;19663-19666.
142. Richards I.M., Kolbasa K.P., Hatfield C.A., Winterrowd G.E., Vonderfecht S.L., Fidler S.F., Griffin R.L., Brashler J.R., Krzesicki R.F., Sly L.M., Ready K.A., Staite N.D., Chin J.E. Role of very late activation antigen-4 in the antigen-induced accumulation of eosinophils and lymphocytes in the lungs and airway lumen of sensitized Brown Norway rats. Am. J. Respir. Cell Mol. Biol. 15:1996;172-183.
143. Riva C.M., Morganroth M.L., Ljungman A.G., Schoeneich S.O., Marks R.M., Todd R.F. III, Ward P.A., Boxer L.A. Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers. Am. J. Respir. Cell Mol. Biol. 3:1990;301-309.
144. Ross L., Hassman F., Molony L. Inhibition of Molt-4-endothelial adherence by synthetic peptides from the sequence of ICAM-1. J. Biol. Chem. 267:1992;8537-8543.
145. Rothlein R., Mainolfi E.A., Czajkowski M., Marlin S.D. A form of circulating ICAM-1 in human serum. J. Immunol. 147:1991;3788-3793.
146. Salmi M., Kalimo K., Jalkanen S. Induction and function of vascular adhesion protein-1 at sites of inflammation. J. Exp. Med. 178:1993;2255-2260.
147. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry. 34:1995;14609-14615.
148. Seth R., Raymond F.D., Makgoba M.W. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet. 338:1991;83-84.
149. Smith R.J., Justen J.M., Bleasdale J.E., Sly L.M. NPC 15669-modulated human polymorphonuclear neutrophil functional responsiveness: effects on receptor-coupled signal transduction. Br. J. Pharmacol. 114:1995;1694-1702.
150. Spragg D.D., Alford D.R., Greferath R., Larsen C.E., Lee K.-D., Gurtner G.C., Cybulsky M.I., Tosi P.F., Nicolau C., Gimbrone M.A. Jr. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc. Natl. Acad. Sci. USA. 94:1997;8795-8800.
151. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
152. Staunton D.E., Dustin M.L., Springer T.A. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature. 339:1989;61-64.
153. Steegmaier M., Levinovitz A., Isenmann S., Borgers E., Lenter M., Kocher H.P., Kleuser B., Vestweber D. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature. 373:1995;615-620.
154. Stepkowski S.M., Tu Y., Condon T.P., Bennett C.F. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other suppressive modalities. J. Immunol. 153:1994;5336-5346.
155. Stepkowski S.M., Wang M.E., Amante A., Kalinin D., Qu X., Blasdel T., Condon T., Kahan B.D., Bennett F.C. Antisense ICAM-1 oligonucleotides block allograft rejection in rats. Transplant. Proc. 29:1997;1285.
156. Stewart A.J., Pichon C., Meunier L., Midoux P., Monsigny M., Roche A.C. Enhanced biological activity of antisense oligonucleotides complexed with glycosylated poly-L-lysine. Mol. Pharmacol. 50:1996;1487-1494.
157. Tailor A., Das A.M., Getting S.J., Flower R.J., Perretti M. Subacute treatment of rats with dexamethasone reduces ICAM-1 levels on circulating
158. Takahashi N., Liu M.C., Proud D., Yu X.-Y., Hasegawa S., Spannhake E.W. Soluble intracellular adhesion molecule 1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge. Am. J. Respir. Crit. Care Med. 150:1994;704-709.
159. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 251:1991;1451-1455.
160. Tam S.H., Nakada M.T., Kruszynski M., Fieles W.E., Taylor A.H., Mervic M., Heavner G.A. Structure-function studies on synthetic peptides derived from the 109-118 lectin domain of selectins. Biochem. Biophys. Res. Commun. 227:1996;712-717.
161. Thornhill M.H., Haskard D.O. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ J. Immunol. 145:1990;865-872.
162. Thornhill M.H., Wellicome S.M., Mahiouz D.L., Lanchbury J.S.S., Kyan-Aung U., Haskard D.O. Tumor necrosis factor combines with IL-4 or INF-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J. Immunol. 146:1991;592-598.
163. Uthoff K., Zehr K.J., Lee P.C., Low R.A., Baumgartner W.A., Cameron D.E., Stuart R.S. Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation. Ann. Thorac. Surg. 59:1995;7-13.
164. 4 integrins. J. Immunol. 158:1997;1710-1718.
165. Van de Stolpe A., Van der Saag P.T. Intercellular adhesion molecule-1. J. Mol. Med. 74:1996;13-33.
166. Van de Stolpe A., Caldenhoven E., Raaijmakers J.A.M., Van der Saag P.T., Koenderman L. Glucocorticoid-mediated repression of intracellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am. J. Respir. Cell Mol. Biol. 8:1993;340-347.
167. Van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A.M., Johnson J.P., Van der Saag P.T. 12-O-tetradecanoylphorbol-13-acetate and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecule-1 promoter. J. Biol. Chem. 269:1994;6185-6192.
168. Van Seventer G.A., Newman W., Shimizu Y., Nutman T.B., Tanaka Y., Horgan K.J., Gopal T.V., Ennis E., O'Sullivan D., Grey H., Shaw S. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J. Exp. Med. 174:1991;901-913.
169. Varki A. Selectin ligands. Proc. Natl. Acad. Sci. USA. 91:1994;7390-7397.
170. Varki A. Selectin ligands: will the real ones please stand up? J. Clin. Invest. 99:1997;158-162.
171. Vingerhoeds M.H., Storm G., Crommelin D.J.A. Immunoliposomes in vivo. Immunomethods. 4:1994;259-272.
172. Wacholtz M.C., Patel S.S., Lipsky P.E. Leukocyte function-associated antigen 1 is an activation molecule for human T cells. J. Exp. Med. 170:1989;431-448.
173. 4 integrin interaction. Proc. Natl. Acad. Sci. USA. 92:1995;5714-5718.
174. Wegner C.D., Gundell R.H., Reilly P., Hayness N., Letts L.G., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science. 247:1990;456-459.
175. Wheller S.K., Perretti M. Dexamethasone inhibits cytokine-induced intercellular adhesion molecule-1 up-regulation on endothelial cell lines. Eur. J. Pharmacol. 331:1997;65-71.
176. Wilckens T., De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol. Today. 18:1997;418-424.
177. Williams A.F., Barclay A.N. The immunoglobulin superfamily. Annu. Rev. Immunol. 6:1988;381-405.
178. Yoshida N., Takemura T., Granger D.N., Anderson D.C., Wolf R.E., McIntire L.V., Kvietys P.R. Molecular determinants of aspirin-induced neutrophil adherence to endothelial cells. Gastroenterology. 105:1993;715-724.
179. Yoshida N., Cepinskas G., Granger D.N., Anderson D.C., Wolf R.E., Kvietys P.R. Aspirin-induced, neutrophil-mediated injury to vascular endothelium. Inflammation. 19:1995;297-312.
180. Zangrilli J.G., Shaver J.R., Cirelli R.A., Cho S.K., Garlisi C.G., Falcone A., Cuss F.M., Fish J.E., Peters S.P. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am. J. Respir. Crit. Care Med. 151:1995;1346-1353.
181. Zhou L., Pope B.L., Chourmouzis E., Fung-Leung W.-P., Lau C.Y. Tepoxalin blocks neutrophil migration into cutaneous inflammatory sites by inhibiting Mac-1 and E-selectin expression. Eur. J. Immunol. 26:1996;120-129.